From Intention to Action:Scoring Your College Goals

NCT05047081 | Unknown

• 1 other identifier: 21-0500
• Study Type: interventional
• Target: 126
• Locations: 1 country
• Sites: 1

Brief Summary

The current study aims to prevent the developmental of mental health symptoms in first-year college students through providing a workshop aimed at preparing students for the academic, social, and personal challenges associated with typical college experiences. Specifically, the study hypothesizes that first-year student students who participate in a workshop on college readiness will report fewer symptoms of depression and anxiety, higher levels of self-esteem, and better academic performance compared to a similar group of students who do not receive the intervention (the control group). Students in the intervention group will participate in a one-time, two-hour workshop that discusses expectations about college, setting goals that are aligned with one's values, predicting barriers to achieving these goals, and how to overcome these obstacles. The workshop will provide students with external resources (both on and off campus) for obtaining additional support to address barriers that arise during their college experiences. Students will complete questionnaires about symptoms of depression, anxiety, and their ability to cope with stress before the workshop, after the workshop, and at the end of their first semester. At the end of the Fall 2021 semester, students will be asked to share information about their Grade Point Average (GPA) and academic status. The investigators predict that at the end of the semester, those students who participated in the workshop will report lower levels of depression, anxiety and stress, higher levels of self-esteem, and a higher GPA compared to students who did not receive the intervention. Students who participated in the workshop will also be more likely to continue (enrolled in the Spring 2022 semester) compared to controls.

Conditions

Depression; Anxiety

Keywords

Depression; Anxiety; College Mental Health; Mental Health Prevention

Outcome Measures

Primary Outcomes (2)

• Change in Self-Reported Depression Symptoms on the DASS-21

  Change in Depression Symptoms as measured by self-report on the Depression sub scale of the Depression, Anxiety and Stress Scale (DASS-21). Each sub scale of the DASS-21 has a range of 0-(lowest) to 42 (highest) with higher scores indicating worsening levels of psychopathology.

  Three Months

• Change in Anxiety Symptoms as measured by the DASS-21

  Participants in the intervention arm but not the placebo group will demonstrate change in Depression Symptoms as measured by participant self-report on the Anxiety subscale of the Depression, Anxiety and Stress Scale (DASS-21).

  Three Months

Secondary Outcomes (2)

• Change in self-efficacy as measured by the Coping Self-Efficacy Scale

  Three Months

• Change in Coping abilities as measured by the Brief COPE

  Three Months

Study Arms (2)

College Workshop Arm

EXPERIMENTAL

Intervention

Behavioral: Scoring Your College Goals Workshop

Placebo

PLACEBO COMPARATOR

Placebo

Other: Placebo

Interventions

Scoring Your College Goals Workshop BEHAVIORAL

A two-hour virtual college readiness workshop.

College Workshop Arm

Placebo OTHER

Placebo Treatment-As-Usual Group which does not receive the workshop intervention

Placebo

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• First-year, first semester freshman enrolled in Psychology 100 courses at CUNY College of Staten Island.

You may not qualify if:

• Under 18 years old

Sponsors & Collaborators

• The Zucker Hillside Hospital: lead
• College of Staten Island, the City University of New York: collaborator

Study Sites (1)

CUNY College of State Island

Staten Island, New York, 10314, United States

Location

MeSH Terms

Conditions

Depression; Anxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior; Mental Disorders

Study Officials

• Timothy I Michaels, PhD

  The Zucker Hillside Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: August 31, 2021
• First Posted: September 16, 2021
• Study Start: August 27, 2021
• Primary Completion: March 1, 2022
• Study Completion: April 30, 2022
• Last Updated: February 25, 2022

Record last verified: 2022-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)